Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer

BACKGROUND: Immunotherapy is considered as a powerful and promising clinical approach for the treatment of gastric cancer (GC). However, it is still challenging to precisely screen patients who potentially benefit from immune checkpoint therapy (ICT). Identification of potential biomarkers for selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuning, Wang, Shixiang, Han, Yalin, Xu, Maolin, Li, Peng, Ke, Mu, Teng, Zhipeng, Huang, Pu, Diao, Ziyan, Yan, Yongfeng, Meng, Qingyu, Kuang, Yanshen, Zheng, Wei, Liu, Hongyi, Liu, Xuesong, Jia, Baoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605807/
https://www.ncbi.nlm.nih.gov/pubmed/34815701
http://dx.doi.org/10.2147/IJGM.S325910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605807/
https://www.ncbi.nlm.nih.gov/pubmed/34815701
http://dx.doi.org/10.2147/IJGM.S325910

Ejemplares similares